VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,084,333 | -11.5% | 40,295 | -0.9% | 0.05% | -8.5% |
| Q2 2023 | $1,224,634 | -8.1% | 40,672 | -1.2% | 0.06% | -28.0% |
| Q1 2023 | $1,332,270 | +26.4% | 41,183 | +12.0% | 0.08% | +9.3% |
| Q4 2022 | $1,054,211 | +16.2% | 36,783 | -2.2% | 0.08% | 0.0% |
| Q3 2022 | $907,000 | -15.9% | 37,608 | -4.4% | 0.08% | -16.7% |
| Q2 2022 | $1,078,000 | -54.1% | 39,356 | -35.7% | 0.09% | -46.1% |
| Q1 2022 | $2,348,000 | +256.8% | 61,225 | +199.0% | 0.17% | +240.8% |
| Q4 2021 | $658,000 | +8.9% | 20,476 | -0.2% | 0.05% | -41.0% |
| Q3 2021 | $604,000 | – | 20,508 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |